| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 4,716,000 | 3,720,000 | 2,874,000 | 2,242,000 | | Cost of Revenue | 3,001,000 | 2,424,000 | 1,846,000 | 1,339,000 | | | Gross Profit | 1,715,000 | 1,296,000 | 1,028,000 | 903,000 | | | Operating Expenses | | Research Development | 119,000 | 111,000 | 90,000 | 77,000 | | Selling General and Administrative | 999,000 | 822,000 | 522,000 | 511,000 | | Non Recurring | 4,000 | 23,000 | 157,000 | (126,000) | | Others | 165,000 | 141,000 | 96,000 | 78,000 | | | | Total Operating Expenses | 1,287,000 | 1,097,000 | 865,000 | 540,000 | | | | Operating Income or Loss | 428,000 | 199,000 | 163,000 | 363,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 52,000 | 29,000 | 155,000 | (66,000) | | Earnings Before Interest And Taxes | 480,000 | 228,000 | 318,000 | 297,000 | | Interest Expense | 65,000 | 66,000 | 26,000 | 22,000 | | Income Before Tax | 415,000 | 162,000 | 292,000 | 275,000 | | Income Tax Expense | 124,000 | 49,000 | 82,000 | 81,000 | | Minority Interest | (28,000) | (26,000) | (17,000) | (15,000) | | | | Net Income From Continuing Ops | 263,000 | 87,000 | 193,000 | 179,000 | | | Non-recurring Events | | Discontinued Operations | (13,000) | 13,000 | 7,000 | 12,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 250,000 | 100,000 | 200,000 | 191,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $250,000 | $100,000 | $200,000 | $191,000 |
|
1.49% Nasdaq 
0.27%
Income Statement
